about
APC/C and retinoblastoma interaction: cross-talk of retinoblastoma protein with the ubiquitin proteasome pathwaymiR-375 activates p21 and suppresses telomerase activity by coordinately regulating HPV E6/E7, E6AP, CIP2A, and 14-3-3ζEgg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells via SKP2/P27 signaling pathway.Ablation of galectin-3 induces p27(KIP1)-dependent premature senescence without oncogenic stressPrognostic biomarkers in squamous cell carcinoma of the anus: a systematic review.Generation of a Retinoblastoma (Rb)1-inducible dominant-negative (DN) mouse model.Tumour suppressor genes in chemotherapeutic drug response.Aberrant DNA methylation in human cancers.MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.MiR-26a regulates cell cycle and anoikis of human esophageal adenocarcinoma cells through Rb1-E2F1 signaling pathway.Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640.A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer.Targeting Rb mutant cancers by inactivating TSC2.Targeting the RB-pathway in cancer therapy.Cell Cycle Protein Expression in Neuroendocrine Tumors: Association of CDK4/CDK6, CCND1, and Phosphorylated Retinoblastoma Protein With Proliferative Index.miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas.Retinoblastoma protein determines aggressiveness in triple-negative breast cancer.
P2860
Q28072560-8B6C1ACD-C85B-4EAE-9E37-FEE795A1AC63Q33614271-84B36AE7-B2D3-4E9F-A33D-515AF569C14DQ33670909-E1B6A148-DA9F-4128-B90A-A7DAFBB9C334Q34413483-71DAE7FE-1DE0-47F8-A7B1-23A1E0C71F59Q34433781-0937A6D5-38B5-4BAD-A6C5-C47A50F0BA21Q35110344-05B4AACF-2D06-4511-883D-3E3202F7E763Q36083098-C130B876-4DD0-4A21-8F52-4F5E62D9F194Q38171316-33F90ED1-3C7F-4740-8F2E-7EE363673E78Q38261708-663BA164-2411-4765-9C6D-B1FCE77627DAQ39251789-7D4733F4-0C6C-4413-B70A-0DDC461CEB1AQ39496138-F1C51EBC-D22D-4E0F-9D36-6A85DFF51E1BQ39610270-BDE5FAB0-B0A3-4892-841C-5FAFE4BB9562Q41998615-A97D7E80-F7F6-438F-93F5-DD901D0EE692Q42021453-0F2B54FE-3F16-4BC2-AAD7-17F5641CDF33Q47677607-AEA73AFE-4693-4C17-84D0-8356DCF5DA5CQ48411575-A6220EB5-726D-4BB2-87EA-530B82931160Q49185712-04954E8F-BF3E-4B7F-BC9D-22E0D58074A4
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The rb pathway and cancer therapeutics
@ast
The rb pathway and cancer therapeutics
@en
type
label
The rb pathway and cancer therapeutics
@ast
The rb pathway and cancer therapeutics
@en
prefLabel
The rb pathway and cancer therapeutics
@ast
The rb pathway and cancer therapeutics
@en
P2860
P1433
P1476
The rb pathway and cancer therapeutics
@en
P2860
P304
P356
10.2174/138945009788680392
P577
2009-07-01T00:00:00Z